2009
DOI: 10.1007/s00432-009-0707-0
|View full text |Cite
|
Sign up to set email alerts
|

TNF superfamily gene polymorphism as prognostic factor in early breast cancer

Abstract: The TNFSF10 (rs1131532) polymorphism was identified as a possible prognostic factor of survival in patients with operated invasive breast cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
13
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 34 publications
2
13
0
Order By: Relevance
“…This speculation agrees with findings from direct studies on FASL expression in breast cancer showing that FASL did not influence patient outcome [13]. Our findings are also consistent with those of Jung et al showing that FASLÀ844 T/C polymorphism had no prognostic effect on survival in patients with early breast cancer [43]. Moreover, no evidence of association of this polymorphism with DFS was reported in Caucasian patients with breast cancer [44].…”
Section: Discussionsupporting
confidence: 94%
“…This speculation agrees with findings from direct studies on FASL expression in breast cancer showing that FASL did not influence patient outcome [13]. Our findings are also consistent with those of Jung et al showing that FASLÀ844 T/C polymorphism had no prognostic effect on survival in patients with early breast cancer [43]. Moreover, no evidence of association of this polymorphism with DFS was reported in Caucasian patients with breast cancer [44].…”
Section: Discussionsupporting
confidence: 94%
“…We also found that the TT genotype at nucleotide 1595 in TRAIL engendered a lower risk of FLD and a less severe form of steatosis in FLD patients in a Chinese population (Yan et al, 2009). Recently, the TRAIL SNP rs1131532 was identified as a possible prognostic factor for survival in patients operated on for invasive breast cancer (Jung et al, 2010). In addition, a promoter SNP in TRAIL was shown to functionally modulate the role of TRAIL in breast cancer pathogenesis (Pal et al, 2011).…”
Section: Discussionmentioning
confidence: 78%
“…Here we show an association between T4EM lymphocytes radiosensitivity and three SNPs within the TRAIL/TNFSF10- gene. Interestingly, these same SNPs were associated with risk and/or treatment outcome in ovarian and breast cancer [24-26]. Further investigation is now needed to understand if and/or how these genetic variants influence TRAIL/TNFSF10 mRNA level.…”
Section: Discussionmentioning
confidence: 99%